[1]
Piotr Szczepański, “EFFICACY AND SAFETY OF ORAL JANUS KINASE INHIBITORS FOR ATOPIC DERMATITIS: A NARRATIVE REVIEW”, IJITSS, vol. 3, no. 1(49), Mar. 2026, doi: 10.31435/ijitss.1(49).2026.4540.